Anpac Bio-Medical Science Co.'s Series B Round

Anpac Bio-Medical Science Co. raised a round of funding on December 27, 2015. Investors include Shanghai Zhangjiang Science & Technology Investment.

Anpac's proprietary CDA medical devices effectively reinvent cancer screening and early cancer detection by analyzing simple, standard, non-invasive "Blood Biopsies" – resulting in measurably greate…

Articles about Anpac Bio-Medical Science Co.'s Series B Round: